RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCOPUS SCIE

      From bedside to bench: regulation of host factors in SARS-CoV-2 infection

      한글로보기

      https://www.riss.kr/link?id=A107358343

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      The zoonotic coronavirus SARS-CoV-2 (severe acute respiratory syndrome coronavirus-2), which causes COVID-19 (coronavirus disease-2019), has resulted in a pandemic. This has led to an urgent need to understand the molecular determinants of SARS-CoV-2 ...

      The zoonotic coronavirus SARS-CoV-2 (severe acute respiratory syndrome coronavirus-2), which causes COVID-19 (coronavirus disease-2019), has resulted in a pandemic. This has led to an urgent need to understand the molecular determinants of SARS-CoV-2 infection, factors associated with COVID-19 heterogeneity and severity, and therapeutic options for these patients. In this review, we discuss the role of host factors in SARS-CoV-2 infection and describe variations in host factor expression as mechanisms underlying the symptoms and severity of COVID-19. We focus on two host factors, angiotensin-converting enzyme 2 (ACE2) and transmembrane serine protease 2 (TMPRSS2), implicated in SARS-CoV-2 infection. We also discuss genetic variants associated with COVID-19 severity revealed in selected patients and based on genome-wide association studies (GWASs). Furthermore, we highlight important advances in cell and chromatin biology, such as single-cell RNA and chromatin sequencing and chromosomal conformation assays, as methods that may aid in the discovery of viral–host interactions in COVID-19. Understanding how regulation of host factor genes varies in physiological and pathological states might explain the heterogeneity observed in SARS-CoV-2 infection, help identify pathways for therapeutic development, and identify patients most likely to progress to severe COVID-19.

      더보기

      참고문헌 (Reference)

      1 Zheng, S., "Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020 : Retrospective cohort study" 369 : m1443-, 2020

      2 Zhang, X., "Viral and host factors related to the clinical outcome of COVID-19" 583 : 437-440, 2020

      3 Kasowski, M., "Variation in transcription factor binding among humans" 328 : 232-235, 2010

      4 Hung, I. F. N., "Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19 : an open-label, randomised, phase 2 trial" 395 : 1695-1704, 2020

      5 Simon C. Biddie, "Transcription Factor AP1 Potentiates Chromatin Accessibility and Glucocorticoid Receptor Binding" Elsevier BV 43 (43): 145-155, 2011

      6 Jesse R. Dixon, "Topological domains in mammalian genomes identified by analysis of chromatin interactions" Springer Science and Business Media LLC 485 (485): 376-380, 2012

      7 Carlos Salama, "Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia" Massachusetts Medical Society 384 (384): 20-30, 2021

      8 Parascandola, M., "Tobacco and the lung cancer epidemic in China" 8 : S21-S30, 2019

      9 David A. Dorward, "Tissue-Specific Immunopathology in Fatal COVID-19" American Thoracic Society 203 (203): 192-201, 2021

      10 Pan, F., "Time course of lung changes on chest CT during recovery From 2019 novel coronavirus(COVID-19)pneumonia" 295 : 715-721, 2020

      1 Zheng, S., "Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020 : Retrospective cohort study" 369 : m1443-, 2020

      2 Zhang, X., "Viral and host factors related to the clinical outcome of COVID-19" 583 : 437-440, 2020

      3 Kasowski, M., "Variation in transcription factor binding among humans" 328 : 232-235, 2010

      4 Hung, I. F. N., "Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19 : an open-label, randomised, phase 2 trial" 395 : 1695-1704, 2020

      5 Simon C. Biddie, "Transcription Factor AP1 Potentiates Chromatin Accessibility and Glucocorticoid Receptor Binding" Elsevier BV 43 (43): 145-155, 2011

      6 Jesse R. Dixon, "Topological domains in mammalian genomes identified by analysis of chromatin interactions" Springer Science and Business Media LLC 485 (485): 376-380, 2012

      7 Carlos Salama, "Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia" Massachusetts Medical Society 384 (384): 20-30, 2021

      8 Parascandola, M., "Tobacco and the lung cancer epidemic in China" 8 : S21-S30, 2019

      9 David A. Dorward, "Tissue-Specific Immunopathology in Fatal COVID-19" American Thoracic Society 203 (203): 192-201, 2021

      10 Pan, F., "Time course of lung changes on chest CT during recovery From 2019 novel coronavirus(COVID-19)pneumonia" 295 : 715-721, 2020

      11 Thavarajah, T., "The plasma peptides of sepsis" 17 : 26-, 2020

      12 Karczewski, K. J., "The mutational constraint spectrum quantified from variation in 141, 456 humans" 581 : 434-443, 2020

      13 Thurman, R. E., "The accessible chromatin landscape of the human genome" 489 : 75-82, 2012

      14 Vaarala, M. H., "The TMPRSS2gene encoding transmembrane serine protease is overexpressed in a majority of prostate cancer patients : detection of mutated TMPRSS2 form in a case of aggressive disease" 94 : 705-710, 2001

      15 GTEx Consortium., "The Genotype-Tissue Expression(GTEx)pilot analysis : multitissue gene regulation in humans" 348 : 648-660, 2015

      16 Chen, L., "The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2" 116 : 1097-1100, 2020

      17 To, K. K. W., "Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV2 : an observational cohort study" 20 : 565-574, 2020

      18 Zang, R., "TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes" 5 : eabc3582-, 2020

      19 Maurano, M. T., "Systematic localization of common disease-associated variation in regulatory DNA" 337 : 1190-1195, 2012

      20 Melnikov, A., "Systematic dissection and optimization of inducible enhancers in human cells using a massively parallel reporter assay" 30 : 271-277, 2012

      21 Zou, X., "Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection" 14 : 185-192, 2020

      22 Zhao, Y., "Single-cell RNA expression profiling of ACE2, the receptor of SARS-CoV-2" 202 : 756-759, 2020

      23 Wang, A., "Single cell multiomic profiling of human lung reveals cell type-specific and age-dynamic control of SARS-CoV2 host genes" 9 : e62522-, 2020

      24 Qi, F., "Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses" 526 : 135-140, 2020

      25 Baratchian, M., "Sex, androgens and regulation of pulmonary AR, TMPRSS2 and ACE2"

      26 Liu, J., "Sex differences in renal angiotensin converting enzyme 2(ACE2)activity are 17β-oestradiol-dependent and sex chromosome-independent" 1 : 6-, 2010

      27 Giacomelli, A., "Self-reported olfactory and taste disorders in SARS-CoV-2 patients : a cross-sectional study" 71 : 889-890, 2020

      28 Pujadas, E., "SARS-CoV-2 viral load predicts COVID-19 mortality" 8 : e70-, 2020

      29 Fajnzylber, J., "SARS-CoV-2 viral load is associated with increased disease severity and mortality" 11 : 1-9, 2020

      30 Ziegler, C. G. K., "SARS-CoV-2 receptor ACE2 Is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues" 181 : 1016-1035, 2020

      31 Lukassen, S., "SARS-CoV-2 receptor ACE 2 and TMPRSS 2 are primarily expressed in bronchial transient secretory cells" 39 : e10511-, 2020

      32 Sungnak, W., "SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes" 26 : 681-687, 2020

      33 Wang, J., "Respiratory influenza virus infection induces intestinal immune injury via microbiotamediated Th17 cell-dependent inflammation" 211 : 2397-2410, 2014

      34 WHO Solidarity Trial Consortium, Pan, H., "Repurposed antiviral drugs for covid-19—interim WHO solidarity trial results" 384 : 497-511, 2020

      35 Zhao, J., "Relationship between the ABO Blood Group and the COVID-19susceptibility" ciaa1150-, 2020

      36 Tomlins, S. A., "Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer" 310 : 644-648, 2005

      37 Wan, Y., "Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus" 94 : e00127-20, 2020

      38 Bukowska, A., "Protective regulation of the ACE2/ACE gene expression by estrogen in human atrial tissue from elderly men" 242 : 1412-1423, 2017

      39 Lin, B., "Prostate-localized and androgen-regulated expression of the membrane-bound serine protease TMPRSS2" 59 : 4180-4184, 1999

      40 Szabo, Q., "Principles of genome folding into topologically associating domains" 5 : eaaw1668-, 2019

      41 Xu, Z., "Pathological findings of COVID-19 associated with acute respiratory distress syndrome" 8 : 420-422, 2020

      42 Yang, J., "Pathological Ace2-to-Ace enzyme switch in the stressed heart is transcriptionally controlled by the endothelial Brg1-FoxM1 complex" 113 : E5628-E5635, 2016

      43 최윤영, "Oligoadenylate synthase-like (OASL) proteins: dual functions and associations with diseases" 생화학분자생물학회 47 : 1-8, 2015

      44 Chen, L., "Ocular manifestations of a hospitalised patient with confirmed 2019 novel coronavirus disease" 104 : 748-751, 2020

      45 Bunyavanich, S., "Nasal gene expression of angiotensinconverting enzyme 2 in children and adults" 363 : 2427-2429, 2020

      46 Puelles, V. G., "Multiorgan and renal tropism of SARS-CoV-2" 383 : 590-592, 2020

      47 Yang, X. H., "Mice transgenic for human angiotensin-converting enzyme 2 provide a model for SARS coronavirus infection" 57 : 450-459, 2007

      48 Lucas, C., "Longitudinal analyses reveal immunological misfiring in severe COVID-19" 584 : 463-469, 2020

      49 Tukiainen, T., "Landscape of X chromosome inactivation across human tissues" 550 : 244-248, 2017

      50 REMAP-CAP Investigators, "Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19" Massachusetts Medical Society 384 (384): 1491-1502, 2021

      51 Onabajo, O. O., "Interferons and viruses induce a novel truncated ACE2 isoform and not the full-length SARS-CoV-2 receptor" 52 : 1283-1293, 2020

      52 Leung, D., "Integrative analysis of haplotype-resolved epigenomes across human tissues" 518 : 350-354, 2015

      53 Muus, C., "Integrated analyses of single-cell atlases reveal age, gender, and smoking status associations with cell type-specific expression of mediators of SARS-CoV-2 viral entry and highlights inflammatory programs in putative target cells"

      54 Chen, J., "Individual variation of the SARS-CoV-2 receptor ACE2 gene expression and regulation" 19 : e13168-, 2020

      55 Zhang, Q., "Inborn errors of type I IFN immunity in patients with lifethreatening COVID-19" 370 : eabd4570-, 2020

      56 Hadjadj, J., "Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients" 369 : 718-724, 2020

      57 Breidenbach, J. D., "Impact of comorbidities on SARS-CoV-2 viral entryrelated genes" 10 : 1-11, 2020

      58 Blanco-Melo, D., "Imbalanced host response to SARS-CoV-2 drives development of COVID-19" 181 : 1036-1045, 2020

      59 Cheng, Z., "Identification of TMPRSS2 as a susceptibility gene for severe 2009 pandemic A(H1N1)influenza and A(H7N9)influenza" 212 : 1214-1221, 2015

      60 Hurst, S. M., "IL-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation" 14 : 705-714, 2001

      61 Shepardson, K. M., "IFNAR2 is required for anti-influenza immunity and alters susceptibility to post-influenza bacterial superinfections" 9 : 2589-, 2018

      62 Gadotti, A. C., "IFN-γ is an independent risk factor associated with mortality in patients with moderate and severe COVID-19 infection" 289 : 198171-, 2020

      63 Lee, N., "IFITM3, TLR3, and CD55 Gene SNPs and cumulative genetic risks for severe outcomes in chinese patients With H7N9/H1N1pdm09 influenza" 216 : 97-104, 2017

      64 Vuille-Dit-Bille, R. N., "Human intestine luminal ACE2 and amino acid transporter expression increased by ACE-inhibitors" 47 : 693-670, 2015

      65 Kreins, A. Y., "Human TYK2 deficiency : mycobacterial and viral infections without hyper-IgE syndrome" 212 : 1641-1662, 2015

      66 Kumasaka, N., "High-resolution genetic mapping of putative causal interactions between regions of open chromatin" 51 : 128-137, 2019

      67 Kerpedjiev, P., "HiGlass : web-based visual exploration and analysis of genome interaction maps" 19 : 125-, 2018

      68 Ortiz, M. E., "Heterogeneous expression of the SARS-Coronavirus-2receptor ACE2 in the human respiratory tract" 60 : 102976-, 2020

      69 Zhou, Z., "Heightened innate immune responses in the respiratory tract of COVID-19 patients" 27 : 883-890, 2020

      70 Alexis J. Combes, "Global absence and targeting of protective immune states in severe COVID-19" Springer Science and Business Media LLC 591 (591): 124-130, 2021

      71 Ellinghaus, D., "Genomewide Association Study of Severe Covid-19 with Respiratory Failure" 383 : 1522-1534, 2020

      72 Fingerlin, T. E., "Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis" 45 : 613-620, 2013

      73 Li, B., "Genome-wide CRISPR screen identifies host dependency factors for influenza A virus infection" 11 : 164-, 2020

      74 Bovijn, J., "Genetic variants mimicking therapeutic inhibition of IL-6 receptor signaling and risk of COVID-19" 2 : e658-e659, 2020

      75 Erola Pairo-Castineira, "Genetic mechanisms of critical illness in COVID-19" Springer Science and Business Media LLC 591 (591): 92-98, 2021

      76 Jin, J. M., "Gender differences in patients with COVID-19 : focus on severity and mortality" 8 : 152-, 2020

      77 Tu, X., "Functional polymorphisms of the CCL2 and MBL genes cumulatively increase susceptibility to severe acute respiratory syndrome coronavirus infection" 71 : 101-109, 2015

      78 Li, M. Y., "Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues" 9 : 45-, 2020

      79 Ma, D., "Expression of SARS-CoV-2 receptor ACE2 and TMPRSS2 in human primary conjunctival and pterygium cell lines and in mouse cornea" 34 : 1212-1219, 2020

      80 Cummings, M. J., "Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City : a prospective cohort study" 395 : 1763-1770, 2020

      81 Dong, Y., "Epidemiology of COVID-19 among children in China" 145 : 20200702-, 2020

      82 Varga, Z., "Endothelial cell infection and endotheliitis in COVID-19" 395 : 1417-1418, 2020

      83 Angus, D. C., "Effect of hydrocortisone on mortality and organ support in patients with severe COVID-19 : The REMAP-CAP COVID-19 corticosteroid domain randomized clinical" 324 : 1317-1329, 2020

      84 Baena, E., "ETV1 directs androgen metabolism and confers aggressive prostate cancer in targeted mice and patients" 27 : 683-698, 2013

      85 RECOVERY Collaborative Group, "Dexamethasone in hospitalized patients with covid-19—preliminary report" 384 : 693-704, 2020

      86 Chen, C. H., "Determinants of transcription factor regulatory range" 11 : 2472-, 2020

      87 Hanako Ishida, "Cryo-EM structures of Toll-like receptors in complex with UNC93B1" Springer Science and Business Media LLC 28 (28): 173-180, 2021

      88 Schreiber, J., "Completing the ENCODE3 compendium yields accurate imputations across a variety of assays and human biosamples" 21 : 82-, 2020

      89 Huang, C., "Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China" 39 : 497-506, 2020

      90 Zhou, F., "Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China : a retrospective cohort study" 295 : 1054-1062, 2020

      91 Guan, W., "Clinical characteristics of coronavirus disease 2019 in China" 382 : 1708-1720, 2020

      92 Smith, J. C., "Cigarette smoke exposure and inflammatory signaling increase the expression of the SARS-CoV-2 receptor ACE2 in the respiratory tract" 53 : 514-529, 2020

      93 Wein, A. N., "CXCR6 regulates localization of tissue-resident memory CD8T cells to the airways" 216 : 2748-2762, 2019

      94 Grasselli, G., "Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy" 323 : 1574-1581, 2020

      95 Argyropoulos, K. V., "Association of initial viral load in severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)patients with outcome and symptoms" 190 : 1881-1887, 2020

      96 Li, G., "Assessing ACE2 expression patterns in lung tissues in the pathogenesis of COVID-19" 112 : 102463-, 2020

      97 Chen, Y., "Asians do not exhibit elevated expression or unique genetic polymorphisms for ACE2, the cell-entry receptor of SARSCoV-2"

      98 Imai, Y., "Angiotensin-converting enzyme 2 protects from severe acute lung failure" 436 : 112-116, 2005

      99 Pierre-Jean Lamy, "Androgenic hormones and the excess male mortality observed in COVID-19 patients: new convergent data" Springer Science and Business Media LLC 39 (39): 3121-3123, 2021

      100 Wambier, C. G., "Androgenetic alopecia present in the majority of patients hospitalized with COVID-19 : The"Gabrin sign"" 83 : 680-682, 2020

      101 Schuler, B. A., "Age-determined expression of priming protease TMPRSS2and localization of SARS-CoV-2 in lung epithelium" 131 : e140766-, 2020

      102 Grobe, J. L., "ACE2 overexpression inhibits hypoxia-induced collagen production by cardiac fibroblasts" 113 : 357-364, 2007

      103 Asselta, R., "ACE2 and TMPRSS2 variants and expression as candidates to sex and country differences in COVID-19severity in Italy" 12 : 10087-10098, 2020

      104 Leung, J. M., "ACE-2 expression in the small airway epithelia of smokers and COPD patients : implications for COVID-19" 55 : 2000688-, 2020

      105 Fadason, T., "A transcription regulatory network within the ACE2locus may promote a pro-viral environment for SARS-CoV-2 by modulating expression of host factors"

      106 Hoffmann, M., "A multibasic cleavage site in the spike protein of SARS-CoV-2 Is essential for infection of human lung cells" 78 : 779-784, 2020

      107 Travaglini, K. J., "A molecular cell atlas of the human lung from single-cell RNA sequencing" 587 : 619-625, 2020

      108 Schmitt, A. D., "A compendium of chromatin contact maps reveals spatially active regions in the human genome" 17 : 2042-2059, 2016

      109 Rao, S. S. P., "A 3D map of the human genome at kilobase resolution reveals principles of chromatin looping" 159 : 1665-1680, 2014

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2009-09-21 학회명변경 한글명 : 대한생화학ㆍ분자생물학회 -> 생화학분자생물학회
      영문명 : Korean Society Of Medical Biochemistry And Molecular Biology -> Korean Society Of Biochemistry And Molecular Biology
      KCI등재
      2008-01-01 평가 SCI 등재 (등재유지) KCI등재
      2006-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2004-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2001-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      1998-07-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 3.74 0.23 2.56
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      1.82 1.45 0.555 0.01
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼